| Literature DB >> 33808450 |
Julián Lozano-Castellón1,2, Anallely López-Yerena1, Alexandra Olmo-Cunillera1,2, Olga Jáuregui3,4, Maria Pérez1,5, Rosa Mª Lamuela-Raventós1,2, Anna Vallverdú-Queralt1,2.
Abstract
Extra virgin olive oil (EVOO), one of the key foods of the Mediterranean diet, is distinguished by its high content of nutritional and antioxidant compounds compared to other vegetable oils. During EVOO production, the major secoiridoids of EVOO, oleacein, oleocanthal, ligstroside, and oleuropein aglycones, undergo a series of transformations to open- and closed-structure forms. The resulting mixture of compounds can become more complex during the analytical procedure, due to the keto-enol tautomerism of the open forms and their interaction with polar solvents, and therefore more challenging to analyze. Employing the same extraction method used to analyze the other EVOO phenolic compounds, we report here a simple UHPLC-ESI-MS/MS procedure for the quantification of those secoiridoids that is able to co-elute the different isomers of each compound. The method was validated following AOAC guidelines, and the matrix effect and recoveries were within satisfactory limits.Entities:
Keywords: EVOO analysis; HPLC; Mediterranean diet; mass spectrometry; oleacein; oleocanthal; polyphenols
Year: 2021 PMID: 33808450 PMCID: PMC8066082 DOI: 10.3390/antiox10040540
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Conversion of Oleuropein and Ligstroside to oleuropein aglycone (OLA), oleacein (OLE), ligstroside aglycone (LIG), and oleocanthal (OLC) during oil extraction. Adapted from Abbattista et al., 2019 [10] and adding the closed forms I and II for OLC and OLE, which are possible artifacts.
Electrospray ionization parameters for the secoiridoids (SEC).
| OLE | OLC | OLA | LIG | |
|---|---|---|---|---|
| MRM Transition | 361/291 | 303/285 | 377/275 | 319/69 |
| Declustering Potential | −40 | −40 | −45 | −30 |
| Focusing Potential | −170 | −170 | −140 | −170 |
| Entrance Potential | −5 | −5 | −5 | −5 |
| Collision Energy | −10 | −10 | −15 | −30 |
| Dwell Time (ms) | 150 | 50 | 150 | 50 |
| Retention time (min) | 2.7 | 2.4 | 2.5 | 2.3 |
Figure 2Example chromatogram of oleacein (A), oleocanthal (B), oleuropein aglycone (C), and ligstroside aglycone (D), the latter from a commercial “Picual” EVOO.
Method validation parameters for OLE, OLC, and OLA.
| OLE | OLC | OLA | ||
|---|---|---|---|---|
| Calibration curve | Slope | 27,987 | 33,800 | 82,737 |
| Interception | −19,765 | −7875 | −74,897 | |
| R2 | 0.9991 | 0.9873 | 0.9907 | |
| Weighting | none | 1/x2 | 1/x | |
| Limits | LOD (mg·kg−1) | 0.0343 | 0.0186 | 0.0334 |
| LOQ (mg·kg−1) | 0.114 | 0.0621 | 0.111 | |
| Accuracies | 1 mg·kg−1 | 93% | 107% | 87% |
| 2 mg·kg−1 | 100% | 89% | 101% | |
| 5 mg·kg−1 | 103% | 97% | 113% | |
| 8 mg·kg−1 | 96% | 95% | 98% | |
| 10 mg·kg−1 | 102% | 100% | 110% | |
| 20 mg·kg−1 | 99% | 114% | 94% | |
| Repeatability Relative Standard Deviation | Intraday 1 mg·kg−1 | 2.3% | 2.5% | 5.8% |
| Intraday 5 mg·kg−1 | 1.9% | 2.7% | 1.8% | |
| Intraday10 mg·kg−1 | 1.1% | 5.7% | 3.7% | |
| Interday 1 mg·kg−1 | 2.4% | 3.3% | 7.5% | |
| Interday 5 mg·kg−1 | 5.7% | 4.1% | 7.0% | |
| Interday 10 mg·kg−1 | 1.2% | 6.0% | 3.1% |
Parameter comparison between methods for oleacein (OLE), oleocanthal (OLC) and oleuropein aglycone (OLA).
| LOD | LOQ | R2 | RSD | EVOO | Instrument | Time of Analysis (min) | Study | |
|---|---|---|---|---|---|---|---|---|
| OLE | 0.0343 | 0.114 | 0.999 | 1.8 | 0.5 | UHPLC-ESI-MS/MS | 6.5 | Current study |
| 0.128 | 0.428 | - | 3.1 | 45 | UPLC-ESI-MS/MS | 40 | [ | |
| 0.002 | 0.005 | 0.999 | 10 | 1 | HPLC-ESI-MS/MS | 10 | [ | |
| 0.001 | 0.0033 | 0.995 | 1.9 | 1 | UHPLC-ESI-MS/MS b | 7.5 | [ | |
| 1 | 10 | 0.994 | 4.3 | 5 | NMR | - | [ | |
| OLC | 0.0186 | 0.0621 | 0.987 | 3.6 | 0.5 | UHPLC-ESI-MS/MS | 6.5 | Current study |
| 0.072 | 0.244 | - | 3 | 45 | UPLC-ESI-MS/MS | 40 | [ | |
| 0.004 | 0.01 | 0.992 | 11 | 1 | HPLC-ESI-MS/MS | 10 | [ | |
| 0.004 | 0.012 | 0.994 | 4.4 | 1 | UHPLC-ESI-MS/MS b | 7.5 | [ | |
| 1 | 10 | 0.999 | 4.3 | 5 | NMR | - | [ | |
| OLA | 0.0334 | 0.111 | 0.991 | 3.8 | 0.5 | UPLC-ESI-MS/MS | 6.5 | Current study |
| 0.0003 | 0.0009 | 0.996 | 2.5 | 1 | UHPLC-ESI-MS/MS b | 7.5 | [ | |
| 1 | 10 | 0.999 | 4.1 | 5 | NMR | - | [ |
The parameters were chosen according to the criteria of the authors to help choose the most suitable analytical method. a Relative standard deviation within the same day of analysis, when it was calculated for more than one concentration; the mean of the different RSD is showed in the table. b The chromatographic instrument requires a ternary pump and to be prepared for strong organic solvents.
Matrix effect and recoveries for OLE, OLC, and OLA.
| OLE | OLC | OLA | ||
|---|---|---|---|---|
| Matrix effect (%) | 1 mg·kg−1 | 56 | 93 | 20 |
| 2 mg·kg−1 | 50 | 76 | 27 | |
| 5 mg·kg−1 | 86 | 129 | 57 | |
| 8 mg·kg−1 | 79 | 123 | 51 | |
| 10 mg·kg−1 | 82 | 134 | 56 | |
| 20 mg·kg−1 | 93 | 152 | 69 | |
| Recoveries (%) | 1 mg·kg−1 | 55 | 59 | 66 |
| 2 mg·kg−1 | 98 | 96 | 88 | |
| 5 mg·kg−1 | 80 | 61 | 74 | |
| 8 mg·kg−1 | 96 | 62 | 106 | |
| 10 mg·kg−1 | 89 | 61 | 88 | |
| 20 mg·kg−1 | 94 | 60 | 93 |